Early Use of High-Dose Glucocorticoid for the Management of irAE Is Associated with Poorer Survival in Patients with Advanced Melanoma Treated with Anti–PD-1 Monotherapy
暂无分享，去创建一个
R. Sullivan | K. Flaherty | Dennie T. Frederick | G. Boland | Douglas B. Johnson | A. Shoushtari | G. Long | A. Menzies | D. Lawrence | O. Rahma | Henry T. Quach | X. Bai | G. Kasumova | Gyulnara G. Kasumova | Michelle S. Kim | C. Cui | L. Si | B. Tang | Xiaoting Wei | Jun Guo | Justine V. Cohen | T. Sharova | Jiani Hu | M. Manos | C. Cann | K. Rubin | L. Pallan | Riley M Fadden | Xiaoling Yang | C. Freedman | Michael Zhang | A. Betof Warner | Catriona Harvey | Olivia Ouyang | R. Fadden | J. Cohen | Riley M. Fadden | Krista M. Rubin